KIMBERLY OGLESBY-MCCOWAN: Open Payments
NPI 1801282116 · OXNARD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 10 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $78 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $92 |
| UCB, Inc. | 2 | $40 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Medtronic, Inc. | 1 | $24 |
| Amgen Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: MOUNJARO, Bimzelx, DUPIXENT, PROPEL, TEPEZZA, SHINGRIX.
Industry payments across CA — which companies pay providers there.
